Is Ionis Pharmaceuticals, Inc. (IONS) Stock a Buy After Tryngolza’s FDA Approval?

We recently compiled a list of the 10 Best Innovative Healthcare Stocks to Buy Now. Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) is one of the best healthcare stocks on our list.

TheFly reported on June 25 that H.C. Wainwright increased its price target on IONS to $130 from $125 while maintaining a Buy rating on the shares. The revision followed the U.S. Food and Drug Administration’s approval of Tryngolza.

Is Ionis Pharmaceuticals, Inc. (IONS) Stock a Buy After Tryngolza’s FDA Approval?

In other news, on July 6, Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) announced the completion of enrollment in Cohort 1 of the global Phase 3 REVEAL study evaluating obudanersen (ION582), an investigational RNA-targeted therapy for individuals with Angelman syndrome. The pivotal cohort enrolled 136 participants between the ages of 2 and under 18 with genetically confirmed UBE3A deletion or mutation. The company expects enrollment in the adult cohort, which includes participants aged 18 to 50, to conclude in the third quarter of 2026. Topline results from the REVEAL study are anticipated in the second half of 2027. Ionis stated that the trial was designed with input from the Angelman syndrome community to evaluate the therapy across a broad patient population.

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) is a biotechnology leader in RNA-targeted medicines, pioneering antisense oligonucleotide (ASO) therapies. The company develops treatments for rare, neurological, and cardiometabolic diseases by using ASO, siRNA, and gene-editing technologies to regulate disease-causing proteins and improve drug delivery.

While we acknowledge the risk and potential of IONS as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than IONS and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years 

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1